Concepedia

Julia Hatto

JH

8

Publications

304

Citations

8

H-Index

1995

Active since

Affiliations

Novartis Institutes for BioMedical Research(Current)

Novartis (Switzerland)

Novartis (United States)

Julia Hatto is an author at Novartis Institutes for BioMedical Research specializing in pharmacology, pharmacotherapy, and drug discovery.

Top concepts

Publications per year

1995–2021

8

Publications

8

The Identification of Indacaterol as an Ultralong-Acting Inhaled β<sub>2</sub>-Adrenoceptor Agonist

François Baur, David T. Beattie, David Beer et al. · Journal of Medicinal Chemistry · 2010 · 100 citations · Full text

, , +11

Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway

Ian C. Bruce, Mohammed Shahid Akhlaq, Graham C. Bloomfield et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 47 citations · Full text

, , +10

Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease

Darren Le Grand, Martin Gosling, Urs Baettig et al. · Journal of Medicinal Chemistry · 2021 · 35 citations · Full text

Solubility-Driven Optimization of Phosphodiesterase-4 Inhibitors Leading to a Clinical Candidate

Neil J. Press, Roger Taylor, Joseph D. Fullerton et al. · Journal of Medicinal Chemistry · 2012 · 33 citations · Full text

, , +13

Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma

David A. Sandham, Lucy Barker, Lyndon Brown et al. · ACS Medicinal Chemistry Letters · 2017 · 31 citations · Full text

Rows per page

1–5 of 8